Bioventus Inc. stock is down -4.77% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 3 February’s closed higher than January.
Bioventus Inc. focuses on developing and commercializing treatments that engage and enhance the body's natural healing process. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries. Restorative therapies comprise an ultrasonic bone healing system for fracture care.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!